Thoroughbred Financial Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Sell |
529
-2,264
| -81% | -$877K | 0.01% | 533 |
|
|
2025
Q1 | $1.21M | Buy |
2,793
+319
| +13% | +$139K | 0.08% | 252 |
|
|
2024
Q4 | $912K | Sell |
2,474
-266
| -10% | -$98.1K | 0.06% | 293 |
|
|
2024
Q3 | $1.43M | Buy |
2,740
+24
| +0.9% | +$12.5K | 0.09% | 205 |
|
|
2024
Q2 | $1.47M | Buy |
2,716
+1,766
| +186% | +$956K | 0.1% | 196 |
|
|
2024
Q1 | $492K | Sell |
950
-1,338
| -58% | -$693K | 0.05% | 292 |
|
|
2023
Q4 | $1.08M | Sell |
2,288
-9
| -0.4% | -$4.24K | 0.09% | 220 |
|
|
2023
Q3 | $1M | Buy |
2,297
+1,784
| +348% | +$777K | 0.1% | 209 |
|
|
2023
Q2 | $228K | Sell |
513
-30
| -6% | -$13.3K | 0.03% | 372 |
|
|
2023
Q1 | $250K | Hold |
543
| – | – | 0.04% | 355 |
|
|
2022
Q4 | $278K | Hold |
543
| – | – | 0.05% | 324 |
|
|
2022
Q3 | $246K | Sell |
543
-35
| -6% | -$15.9K | 0.05% | 314 |
|
|
2022
Q2 | $279K | Hold |
578
| – | – | 0.05% | 288 |
|
|
2022
Q1 | $284K | Buy |
+578
| New | +$284K | 0.05% | 310 |
|
|
2020
Q2 | – | Sell |
-927
| Closed | -$210K | – | 228 |
|
|
2020
Q1 | $210K | Sell |
927
-107
| -10% | -$24.2K | 0.07% | 230 |
|
|
2019
Q4 | $312K | Buy |
1,034
+27
| +3% | +$8.15K | 0.1% | 190 |
|
|
2019
Q3 | $242K | Hold |
1,007
| – | – | 0.09% | 206 |
|
|
2019
Q2 | $284K | Buy |
1,007
+228
| +29% | +$64.4K | 0.11% | 154 |
|
|
2019
Q1 | $223K | Buy |
779
+1
| +0.1% | +$286 | 0.09% | 206 |
|
|
2018
Q4 | $204K | Buy |
+778
| New | +$204K | 0.1% | 162 |
|